What is a stock summary page? Click here for an overview.
Business Description
Diva Laboratories Ltd
SIC : 111
ISIN : TW0004153002
Description
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 118.49 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | 500.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.82 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.5 | |||||
| 3-Year EBITDA Growth Rate | 44.2 | |||||
| 3-Year EPS without NRI Growth Rate | 77.1 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.34 | |||||
| 9-Day RSI | 58.75 | |||||
| 14-Day RSI | 58.25 | |||||
| 3-1 Month Momentum % | 3.73 | |||||
| 6-1 Month Momentum % | -13.06 | |||||
| 12-1 Month Momentum % | 1.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.18 | |||||
| Quick Ratio | 3.56 | |||||
| Cash Ratio | 2.39 | |||||
| Days Inventory | 106.74 | |||||
| Days Sales Outstanding | 100 | |||||
| Days Payable | 43.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.99 | |||||
| Dividend Payout Ratio | 0.71 | |||||
| 3-Year Dividend Growth Rate | 68.8 | |||||
| Forward Dividend Yield % | 2.99 | |||||
| 5-Year Yield-on-Cost % | 1.78 | |||||
| Shareholder Yield % | 2.76 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.17 | |||||
| Operating Margin % | 11.9 | |||||
| Net Margin % | 10.86 | |||||
| FCF Margin % | 14.03 | |||||
| ROE % | 9.14 | |||||
| ROA % | 7.28 | |||||
| ROIC % | 16.98 | |||||
| 3-Year ROIIC % | -30.98 | |||||
| ROC (Joel Greenblatt) % | 29.66 | |||||
| ROCE % | 11.28 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.45 | |||||
| PE Ratio without NRI | 23.74 | |||||
| Price-to-Owner-Earnings | 25.01 | |||||
| PEG Ratio | 1.22 | |||||
| PS Ratio | 2.86 | |||||
| PB Ratio | 2.33 | |||||
| Price-to-Tangible-Book | 2.33 | |||||
| Price-to-Free-Cash-Flow | 20.4 | |||||
| Price-to-Operating-Cash-Flow | 20.03 | |||||
| EV-to-EBIT | 16.08 | |||||
| EV-to-EBITDA | 14.7 | |||||
| EV-to-Revenue | 2.16 | |||||
| EV-to-FCF | 16 | |||||
| Price-to-GF-Value | 1.18 | |||||
| Price-to-Projected-FCF | 1.59 | |||||
| Price-to-Median-PS-Value | 1.21 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.95 | |||||
| Price-to-Graham-Number | 1.57 | |||||
| Price-to-Net-Current-Asset-Value | 3.14 | |||||
| Price-to-Net-Cash | 7.23 | |||||
| Earnings Yield (Greenblatt) % | 6.22 | |||||
| FCF Yield % | 4.93 | |||||
| Forward Rate of Return (Yacktman) % | 23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diva Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 862.323 | ||
| EPS (TTM) (NT$) | 1.58 | ||
| Beta | 0.11 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 0.91 | ||
| Volatility % | 34.23 | ||
| 14-Day RSI | 58.25 | ||
| 14-Day ATR (NT$) | 1.711392 | ||
| 20-Day SMA (NT$) | 39.305 | ||
| 12-1 Month Momentum % | 1.7 | ||
| 52-Week Range (NT$) | 31.3 - 55.8 | ||
| Shares Outstanding (Mil) | 58.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diva Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diva Laboratories Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Diva Laboratories Ltd Frequently Asked Questions
What is Diva Laboratories Ltd(ROCO:4153)'s stock price today?
The current price of ROCO:4153 is NT$41.80. The 52 week high of ROCO:4153 is NT$55.80 and 52 week low is NT$31.30.
When is next earnings date of Diva Laboratories Ltd(ROCO:4153)?
The next earnings date of Diva Laboratories Ltd(ROCO:4153) is .
Does Diva Laboratories Ltd(ROCO:4153) pay dividends? If so, how much?
The Dividend Yield %  of Diva Laboratories Ltd(ROCO:4153) is 2.99% (As of Today), Highest Dividend Payout Ratio of Diva Laboratories Ltd(ROCO:4153) was 4.83. The lowest was 0.24. And the median was 0.77. The  Forward Dividend Yield % of Diva Laboratories Ltd(ROCO:4153) is 2.99%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers